Antiretroviral therapy coverage for PMTCT in Libya
Libya: Antiretroviral therapy coverage for PMTCT was 70.0% in 2023. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Libya, 2000–2023
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2023, antiretroviral therapy coverage for pmtct in Libya stood at 70.0%.
Compared with earlier readings it is down 2.8% on the previous year and up 16.7% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Libya peaked at 72.0% in 2018 and was at its lowest, 0.0%, in 2000.
Libya ranks 51st of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Libya, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2016 | 60.0% | — |
| 2017 | 60.0% | +0.0% |
| 2018 | 72.0% | +20.0% |
| 2019 | 71.0% | -1.4% |
| 2020 | 71.0% | +0.0% |
| 2021 | 71.0% | +0.0% |
| 2022 | 72.0% | +1.4% |
| 2023 | 70.0% | -2.8% |
Libya compared with similar countries
- Libya's 70.0% is below the median for upper middle income countries, which is 79.5%, 88% of the median. (22 countries reporting)
- Libya's 70.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 2.2× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 65.8% | 60.0% | 72.0% | 4 |
| 2020s | 71.0% | 70.0% | 72.0% | 4 |
Countries ranked near Libya
- 48 Algeria 74.0% compare
- 49 Gabon 72.0% compare
- 49 Morocco 72.0% compare
- 52 Burkina Faso 69.0% compare
- 52 Central African Republic 69.0% compare
- 54 Dominican Republic 68.0% compare
- 54 Lao People's Democratic Republic 68.0% compare
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,084 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0404 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Libya?
- Antiretroviral therapy coverage for pmtct in Libya was 70.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Libya?
- The highest recorded value was 72.0% in 2018.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Libya?
- The lowest recorded value was 0.0% in 2000.
- How does Libya rank for antiretroviral therapy coverage for pmtct?
- Libya ranks 51st out of 84 countries with data for 2023.
- Is antiretroviral therapy coverage for pmtct rising or falling in Libya?
- Over the last ten years it is up 16.7%. The long-run trend across the full record is volatile.
- Where does this Libya data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).